Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia
Paul K.J.D. de Jonge(Radboud University Nijmegen), Harry Dolstra(Radboud University Nijmegen)
Cited by 17
Related Papers
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
|PLoS ONE|2011|237
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
|Blood|2014|115
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells
|Cancer Immunology Immunotherapy|2020|46
Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicity
|Cytotherapy|2023|8
Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8+ T cells
|Cancer Immunology Immunotherapy|2020|7